| 000 | 01866 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517122052.0 | ||
| 264 | 0 | _c20180827 | |
| 008 | 201808s 0 0 eng d | ||
| 022 | _a1440-1797 | ||
| 024 | 7 |
_a10.1111/nep.12952 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBazzi, Claudio | |
| 245 | 0 | 0 |
_aUrinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy. _h[electronic resource] |
| 260 |
_bNephrology (Carlton, Vic.) _cFeb 2018 |
||
| 300 |
_a175-182 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylglucosaminidase _xurine |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBiomarkers _xurine |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranous _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNephrotic Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aUsui, Tomoko | |
| 700 | 1 | _aRizza, Virginia | |
| 700 | 1 | _aCasellato, Daniela | |
| 700 | 1 | _aGallieni, Maurizio | |
| 700 | 1 | _aNangaku, Masaomi | |
| 773 | 0 |
_tNephrology (Carlton, Vic.) _gvol. 23 _gno. 2 _gp. 175-182 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/nep.12952 _zAvailable from publisher's website |
| 999 |
_c26535807 _d26535807 |
||